Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2021 | 2 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Arrestin-3 differentially regulates platelet GPCR subsets.
Platelets. 2020 Jul 3;31(5):641-645. doi: 10.1080/09537104.2019.1686754. Epub 2019 Nov 4.
Platelets. 2020.
PMID: 31684789
Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19.
Goudswaard LJ, Williams CM, Khalil J, Burley KL, Hamilton F, Arnold D, Milne A, Lewis PA, Heesom KJ, Mundell SJ, Davidson AD, Poole AW, Hers I.
Goudswaard LJ, et al.
J Thromb Haemost. 2023 May;21(5):1307-1321. doi: 10.1016/j.jtha.2023.01.018. Epub 2023 Jan 28.
J Thromb Haemost. 2023.
PMID: 36716966
Free PMC article.
Item in Clipboard
Tetherin/BST2, a physiologically and therapeutically relevant regulator of platelet receptor signalling.
Zhao X, Alibhai D, Sun T, Khalil J, Hutchinson JL, Olzak K, Williams CM, Li Y, Sessions R, Cross S, Seager R, Aungraheeta R, Leard A, McKinnon CM, Phillips D, Zhang L, Poole AW, Banting G, Mundell SJ.
Zhao X, et al.
Blood Adv. 2021 Apr 13;5(7):1884-1898. doi: 10.1182/bloodadvances.2020003182.
Blood Adv. 2021.
PMID: 33792632
Free PMC article.
Item in Clipboard
Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling.
Unsworth AJ, Bye AP, Sage T, Gaspar RS, Eaton N, Drew C, Stainer A, Kriek N, Volberding PJ, Hutchinson JL, Riley R, Jones S, Mundell SJ, Cui W, Falet H, Gibbins JM.
Unsworth AJ, et al.
Haematologica. 2021 Jul 1;106(7):1968-1978. doi: 10.3324/haematol.2019.223529.
Haematologica. 2021.
PMID: 32467143
Free PMC article.
Item in Clipboard
Ticagrelor inverse agonist activity at the P2Y12 receptor is non-reversible versus its endogenous agonist adenosine 5´-diphosphate.
Khalil J, Dimofte T, Roberts T, Keith M, Amaradasa K, Hindle MS, Bancroft S, Hutchinson JL, Naseem K, Johnson T, Mundell SJ.
Khalil J, et al.
Br J Pharmacol. 2024 Jan;181(1):21-35. doi: 10.1111/bph.16204. Epub 2023 Sep 1.
Br J Pharmacol. 2024.
PMID: 37530222
Free PMC article.
Item in Clipboard
Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial.
Johnson TW, Baos S, Collett L, Hutchinson JL, Nkau M, Molina M, Aungraheeta R, Reilly-Stitt C, Bowles R, Reeves BC, Rogers CA, Mundell SJ, Baumbach A, Mumford AD.
Johnson TW, et al.
J Am Heart Assoc. 2020 Dec 15;9(24):e016495. doi: 10.1161/JAHA.120.016495. Epub 2020 Dec 11.
J Am Heart Assoc. 2020.
PMID: 33305660
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite